Announcements Trials
Browse Landscape

Status

Completed 6Recruiting 5Unknown 2Active not recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

Plasma cell 1Other solid neoplasm 1

Conditions

Multiple Myeloma 1Metastatic Solid Tumor Cancers 1

Interventions

pembrolizumab 437Carboplatin 322Nivolumab 292Cyclophosphamide 281Specimen Handling 271Magnetic Resonance Spectroscopy 257Cisplatin 253Paclitaxel 248Radiotherapy 229Gemcitabine 183Biopsy 182Dexamethasone 181durvalumab 168atezolizumab 151Rituximab 138Doxorubicin 135Lenalidomide 134Bevacizumab 133Docetaxel 131Ipilimumab 129Capecitabine 120Radiation 118Oxaliplatin 114Radiosurgery 113Pemetrexed 112Etoposide 111Fluorouracil 110venetoclax 106fludarabine 106Prednisone 97

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × 4-amino-4'-hydroxylaminodiphenylsulfone × Clear all
NCT06126341 2026-02-19

A Study to Identify Barriers to Cellular Therapies for People With Plasma Cell Disorders

Memorial Sloan Kettering Cancer Center

Active not recruiting
49 enrolled
Plasma cell

Multiple Myeloma

NCT03667378 2025-10-28

Investigating the Impact of Proactive Palliative Care

Memorial Sloan Kettering Cancer Center

Active not recruiting
83 enrolled
Other solid neoplasm

Metastatic Solid Tumor Cancers

Data powered by HemOnc (CC BY 4.0) Colophon âš¡